Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 92201-92250 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05522582
Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors
PHASE2Active, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04948463
Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia
PHASE4Recruiting
312 participants
Started: Nov 15, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04972552
Watermelon/UBIQuinone Study
NAActive, not recruiting
70 participants
Started: Nov 15, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05001568
Validation of a New Optimized Nighttime Providence Brace for Personalized Treatment of Adolescent Idiopathic Scoliosis
NAActive, not recruiting
58 participants
Started: Nov 15, 2021 · Completed: Jan 31, 2025
2 conditions1 sponsor1 location
NCT04313712
Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure
N/AActive, not recruiting
30 participants
Started: Nov 15, 2021 · Completed: Feb 28, 2025
2 conditions1 sponsor1 location
NCT04871568
Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein
NARecruiting
100 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05256251
Westlake Longevity Cohort
N/ARecruiting
1,500 participants
Started: Nov 15, 2021 · Completed: Nov 14, 2031
1 condition1 sponsor1 location
NCT04794296
Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
N/ARecruiting
500 participants
Started: Nov 15, 2021 · Completed: Sep 1, 2030
1 condition2 sponsors3 locations
NCT04787848
Chronic Widespread Pain in HIV: Novel Mechanisms and Therapeutics
NARecruiting
200 participants
Started: Nov 15, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04633005
Polypill Strategy for Heart Failure With Reduced Ejection Fraction
PHASE2Active, not recruiting
212 participants
Started: Nov 15, 2021 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05454995
Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II
NAActive, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Nov 15, 2027
1 condition1 sponsor1 location
NCT04819841
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
PHASE1/PHASE2Recruiting
15 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor3 locations
NCT05142592
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
196 participants
Started: Nov 15, 2021 · Completed: Dec 21, 2025
3 conditions1 sponsor7 locations
NCT04940052
Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer
PHASE3Active, not recruiting
153 participants
Started: Nov 15, 2021 · Completed: Jun 4, 2027
1 condition1 sponsor41 locations
NCT04603898
Oxalate Formation From Ascorbic Acid
NARecruiting
136 participants
Started: Nov 15, 2021 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05124041
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy
NARecruiting
140 participants
Started: Nov 15, 2021 · Completed: Dec 15, 2025
5 conditions1 sponsor1 location
NCT04651010
Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)
NARecruiting
50 participants
Started: Nov 15, 2021 · Completed: Aug 15, 2025
1 condition1 sponsor1 location
NCT05036434
Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
PHASE2Enrolling by invitation
30 participants
Started: Nov 15, 2021 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05154318
Efficacy of Pericapsular Nerve Group Block
NARecruiting
100 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05168033
Motor Imagery After Reconstruction of the Anterior Cruciate Ligament
NARecruiting
70 participants
Started: Nov 15, 2021 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT05159466
Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors
N/ARecruiting
30 participants
Started: Nov 15, 2021 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT04809324
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
NARecruiting
1,206 participants
Started: Nov 15, 2021 · Completed: Jun 30, 2028
1 condition1 sponsor3 locations
NCT04851717
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
PHASE2/PHASE3Active, not recruiting
100 participants
Started: Nov 15, 2021 · Completed: Oct 31, 2027
1 condition2 sponsors8 locations
NCT05153785
Perioperative Intravenous Lidocaine in Liver Surgery
PHASE2/PHASE3Recruiting
80 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05455021
Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I
NAActive, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Nov 15, 2026
1 condition1 sponsor2 locations
NCT07041619
Subcutaneous Intersectional Short Pulse Stimulation in Epileptic Patients
NARecruiting
30 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05182307
DurAVR™ THV System: First-In-Human Study
NAActive, not recruiting
50 participants
Started: Nov 15, 2021 · Completed: Jan 31, 2025
3 conditions1 sponsor1 location
NCT04391543
BIOpsychosocial Approach of the CAncer-RElated FAtigue (BIOCARE FActory)
NAActive, not recruiting
86 participants
Started: Nov 15, 2021 · Completed: Feb 15, 2025
1 condition1 sponsor1 location
NCT06341985
DOsimetry and Radiation Induced NAusea in Head and Neck Cancers
N/ARecruiting
180 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor14 locations
NCT06280586
Effectiveness of Intervention in Prevention of Sarcopenia, Frailty and Functional Decline in Pre-frail Community Elderly
NAActive, not recruiting
232 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor2 locations
NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
PHASE1/PHASE2Recruiting
170 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor23 locations
NCT04964739
Gender/Sex & CUD Remission
NAActive, not recruiting
224 participants
Started: Nov 15, 2021 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT03994770
An Engineering-Based Balance Assessment and Training Platform
NARecruiting
20 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05128149
Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
N/ARecruiting
200 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT05112861
A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
PHASE3Active, not recruiting
120 participants
Started: Nov 15, 2021 · Completed: Mar 31, 2025
5 conditions1 sponsor3 locations
NCT05041855
Childhood Obesity Treatment Designed for Low Income and Hispanic Families
NAActive, not recruiting
554 participants
Started: Nov 15, 2021 · Completed: May 31, 2026
7 conditions3 sponsors2 locations
NCT05033301
Evaluating the Effectiveness of the Nurse Ned Clinic
NARecruiting
600 participants
Started: Nov 15, 2021 · Completed: Dec 30, 2026
1 condition5 sponsors1 location
NCT05656053
Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging
N/AActive, not recruiting
30 participants
Started: Nov 15, 2021 · Completed: Sep 30, 2026
2 conditions3 sponsors1 location
NCT05148026
Regional Citrate Anticoagulation for RRT During V-V ECMO
NARecruiting
20 participants
Started: Nov 14, 2021 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05118282
A Coping Skills Program for Children With Asthma
NARecruiting
560 participants
Started: Nov 14, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT05299658
An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS
PHASE2Active, not recruiting
40 participants
Started: Nov 13, 2021 · Completed: Aug 31, 2025
1 condition1 sponsor2 locations
NCT05014464
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma
PHASE2Recruiting
90 participants
Started: Nov 13, 2021 · Completed: Aug 8, 2027
1 condition1 sponsor1 location
NCT05056168
Validation of a Dermatology-Specific Treatment Satisfaction Instrument
N/AActive, not recruiting
120 participants
Started: Nov 13, 2021 · Completed: Dec 31, 2023
1 condition3 sponsors1 location
NCT06110143
Oral Health and Adverse Pregnancy Complications
NARecruiting
600 participants
Started: Nov 13, 2021 · Completed: May 31, 2026
6 conditions1 sponsor3 locations
NCT05152264
Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain
NARecruiting
40 participants
Started: Nov 12, 2021 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05054985
Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.
NARecruiting
73 participants
Started: Nov 12, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05281406
Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At Week 3 After Start of Osimertinib 1st-line Treatment (PACE-LUNG)
PHASE2Recruiting
50 participants
Started: Nov 12, 2021 · Completed: Nov 30, 2026
2 conditions1 sponsor16 locations
NCT04632784
Clinical Trial With Artiflex Presbyopic (Artiplus)
NAActive, not recruiting
49 participants
Started: Nov 12, 2021 · Completed: Nov 26, 2026
5 conditions1 sponsor7 locations
NCT05038332
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
PHASE2Recruiting
136 participants
Started: Nov 12, 2021 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT04940936
Shared Decision Making on Radiation Dose for Lung Malignancies
NARecruiting
40 participants
Started: Nov 12, 2021 · Completed: Aug 31, 2030
5 conditions1 sponsor1 location